Barlow’s Syndrome Market Current Trends, SWOT Analysis, Strategies, Industry Challenges, Business Overview and Forecast Research Study 2027

 Barlow’s syndrome is an abnormality of the mitral valve of the heart. It is a condition in which the leaflets of the mitral valve swell and shifts towards to the left atrium of the heart as the valve closes during ventricular contraction. This abnormality prevents the valve from closing suitably, which causes it to leak.

Barlow’s Syndrome can be caused by various reasons, some of them are calcium buildup, congenital heart defects, radiation treatment, and tumors. Additionally, traumatic injury, disease, or infection can lead to Barlow’s Syndrome.

The global Barlow’s Syndrome market is estimated to lead a healthy growth. The global Barlow’s Syndrome market is majorly driven by increasing geriatric population, rising global population, and rising cardiovascular disorders. According to a report published by the U.S. Population Reference Bureau, nearly 46 million people aged 65 years or more in 2014, and the report estimates that this number would double to reach nearly 98 million people by the end of 2060. Similarly, the 65-and-older age group would reach  up to nearly 24% by 2030 from 15% as of 2015.

Global Barlow’s Syndrome market is expected to grow at a CAGR of 9% during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5596 

Segments  

The global Barlow’s Syndrome market is segmented on the basis of type, treatment, diagnosis, and end-users.

On the basis of the type, the market is segmented as mitral valve stenosis, mitral valve prolapse, and mitral valve regurgitation.

On the basis of the treatment, the market is segmented into medications and surgery. The medications are further sub-segmented into beta-blockers and calcium blockers. Beta-blockers further sub-segmented into Atenolol and Metoprolol. Calcium blockers further sub-segmented into Verapamil and Diltiazem.  

On the basis of the diagnosis, the market is segmented into X-ray, Electrocardiogram, and Echocardiogram.

On the basis of the end user, the market is segmented into hospitals & surgical centers, research institutes, and specialty clinics.

Regional Analysis

North America holds the maximum share of the global Barlow’s Syndrome market in the Americas region. On a regional basis, the Americas region is segmented into North America and South America. North America is segmented into the U.S. and Canada. Increasing geriatric population, rising number of cardiovascular disorders, and growing population have increased the scope of the Barlow’s Syndrome   market in the North American market.

Europe holds  the second largest share of the global Barlow’s Syndrome   market. The European market is expected to grow at a healthy growth during the forecasted period. Various Factors such as availability of advanced treatment facilities, increasing cardiovascular diseases, and skilled medical professionals  are propelling the growth of Barlow’s Syndrome  market in the European region. For instance, according to the European Heart Network, cardiovascular disorders accounted for 45% of the total deaths in 2015. Additionally, increasing government healthcare initiatives and growing research and development activities supported by the government to provide better healthcare treatments are likely to boost the market growth.  

The Asia Pacific is expected to be the fastest growing market owing to increasing incidence of chronic diseases, and fetal disorders. India is the fastest growing region owing to increasing population and increasing geriatric population. Rising awareness, growing standard of living, and availability of new treatment methods are likely to drive the market growth in this region.

The Middle East & Africa is expected to show steady growth in the market . Major factors that are affecting the growth are lack of awareness, and  limited access and availability of treatment facilities. In the Middle East, United Arab Emirates  has accounted for the largest market share owing to the development of healthcare infrastructure, skilled healthcare providers.

Key Players       

Some of the key players in the barlows syndrome market are Abbott, Medtronic, CryoLife, Inc., Lepu Medical Technology Co., Ltd. Boston Scientific Corporation, Micro Interventional Devices, Inc., Neovasc, Inc., Edward Lifesciences Corporation, Sorin Group, TTK HealthCare, and JenaValve Technology, Inc

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/barlow-syndrome-market-5596 

Heart Rate Monitor Market 2020 Global Trend, Segmentation and Opportunities Forecast To 2027

 According to the latest report, the global heart rate monitor market size is predicted to grow at a CAGR of 13.50% during the forecast period 2017 to 2023. A heart rate monitor is a device that is used for the monitoring of pulse or heart rate, this gadget can be non-wearable or wearable and it is embedded with heart rate sensors that can track the most accurate heart rate monitor that monitors a person during rest or any physical activities. Heart rate monitoring plays a very important role in managing diseases.

The rising popularity of wearable diagnostic devices and the rising concerns related to health are the major factors that are driving the growth of the global heart rate monitor market. The rising cases of patients suffering from diabetics and cardiac disorders are adding fuel to the growth of the heart rate monitor market. The global heart rate monitor market provides a comprehensive evaluation of the market. The rising trends of using wearable medical devices for fitness and health issues around the globe have increased over the last few years. The rising awareness around the world in order to prevent several cardiovascular diseases is likely to boost the demand for these devices even further. Obesity and diabetics cases have increased the risk of heart diseases. The involvement of high cost of wearable devices of heart rate monitors is the major restraints of the growth of the global heart rate monitor market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1370 

Regional Analysis

In the Americas, the market exhibits tremendous growth owing to an extensive use of heart rate monitors by the people and healthcare providers in hospitals and clinics. The U.S. is the largest market in the Americas owing to increasing patient population suffering from chronic diseases such as cardiovascular diseases and diabetes. The key players are engaged in product differentiation and geographical expansion to maintain their position in the market.

Europe is the second largest market followed by Asia Pacific. In Europe, the market shows growth opportunities in Germany, the U.K, and France. This growth is due to increasing availability of funds for research and development activities and rising prevalence of diabetes. Strong government support and high healthcare expenditure are driving the growth of the market.

Asia Pacific is the fastest growing market owing to increasing prevalence of diabetes and obesity and high geriatric population in developing regions such as India, China, and Japan, Additionally, increasing demand for technologically advanced wearable medical devices such as smartwatches and chest strap is further boosting the market growth. Moreover, increasing government support and presence of huge opportunity in medical device industry have together fueled the growth of the market in Asia Pacific region.

In the Middle East & Africa, the market exhibits steady growth owing to an increasing demand for healthcare services and positive growth of healthcare industry. The Middle East & African market is governed by increasing availability of tertiary healthcare services and growing awareness about cardiovascular diseases. In Africa, the market shows steady growth due to the limited availability of medical facilities, demand for primary care services, and poor economic condition in the African countries.

Segmentation

The global heart rate monitors market has been segmented on the basis of types, application, and end users. On the basis of the types, the global heart rate monitors market is segmented into wearable and non-wearable devices. The wearable devices are sub-segmented into chest strap, wrist strap, and strapless. Non-wearable devices are sub-segmented into analog and digital. Based on the application, it is segmented into sports, medical, and others. On the basis of the end users, the market is segmented into hospital & clinics, sport medicine centers, professionals, individuals, and others.

Key Players

Some of the major players in this market are Apple (U.S.), Garmin Ltd.(U.S.), Visiomed Group (France), SAMSUNG ELECTRONICS Co. Ltd. (South Korea), Nike (U.S.), Fitbit Inc. (U.S.), Mio Global (South Korea), Beurer GmbH (Germany), Omron Healthcare (Japan), Inc., LG Electronics (South Korea), nu-beca & maxcellent co. (Taiwan),  Motorola, Polar Electro (Finland), TomTom International BV (The Netherlands), Motorola Solutions, Inc. (U.S.), Sony (Japan), and others. Other players are SUUNTO (Finland), MYZONE (U.S.), Wahoo Fitness (U.S.), Moov Inc. (U.S.), Nokia (Finland), Bragi (Germany), Jabra (Germany), Decathlon (France), and Scosche Industries. (U.S.)

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/heart-rate-monitor-market-1370 

Hemifacial Spasm Market Foraying into Emerging Economies 2020-2027

 Hemifacial spasm is a painless neurological condition characterized by persistent or brief involuntary contractions of the muscles innervated by the facial nerve. Vascular compression triggers the primary hemifacial spasm, and secondary hemifacial spasm comprises all other causes of facial nerve damage.

According to the study published in The Scientific World Journal in 2014, it is found that hemifacial spasm is prevalent in 9.8 per 100,000 individuals, and the average age for the onset of hemifacial spasm is 44 years. It is also reported that women and Asian populations have a high susceptibility to hemifacial spasm.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5533 

However, difficult diagnosis, cost of treatment, side-effects of botulinum toxin, the presence of misbranded and spurious drugs, and poor healthcare system in low and middle-income countries may hamper the growth of the market over the review period.

It is estimated that the hemifacial spasm market is expected to grow at a CAGR 7.5% during the forecast period of 2017-2023.

Regional Analysis:

The Americas dominate the hemifacial spasm market owing to the rising technological advancements and high healthcare expenditure. According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion, and hospital care accounted for a share of 32.3%.

Europe holds the second position in the hemifacial spasm market. It is expected that the support provided by the government bodies for research & development and improvement in reimbursement policies in the healthcare is likely to drive the European market.

The Asia Pacific is the fastest growing hemifacial spasm market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare in the years 2015-2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014-2015. An increasing prevalence rate among Asian population is also propelling the growth of the market.

The Middle East & Africa holds the lowest share of the global market due to lack of technical knowledge and poor medical facilities.

Segmentation

The global hemifacial spasm market is segmented on the basis of diagnosis, treatment, and end user.

On the basis of the diagnosis, the market is classified as a magnetic resonance imaging (MRI), computed tomography (CT or CAT scan), angiography (Arteriography), and others.

On the basis of the treatment, the market is classified as medical treatment, surgical treatment, combinational therapy, transcutaneous electric nerve stimulation (TENS) therapy, physical therapy, and others. The medical treatment is further classified into Botulinum Neurotoxin (BoNT) Injections and Pharmaceuticals. The sub-segment of Botulinum Neurotoxin (BoNT) Injections includes BoNT-A, BoNT-B, onabotulinumtoxinA, incobotulinumtoxinA, and rimabotulinumtoxinB. The sub-segment of pharmaceuticals include anticonvulsants, and GABAergic drugs. The surgical treatment is further classified into microvascular decompression (MVD), and others.

On the basis of the end user, the market is segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others.

Key Players

Some of key the players in the global hemifacial spasm market are Abbott, Allergan, Inc., Cephalon Inc., GlaxoSmithKline plc, Ipsen Group, Johnson & Johnson Services, Inc., Medytox,Inc., Merz Pharma GmbH and Co. KGaA, Novartis AG, Pfizer, Revance Therapeutics, Inc., ROCHE, Sanofi S.A, Shire plc, Stryker, Sunovion Pharmaceuticals, Inc., UCB S.A., US WorldMeds, LLC., and Valeant Pharmaceuticals International, Inc.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/hemifacial-spasm-market-5533 

Cheilectomy Market Insights Analysis 2020-2027

 Cheilectomy is a surgical procedure aimed to remove the bony lump present on the top of the metatarsophalangeal joint (big toe). Hallux rigidus, a type of big toe arthritis is a major cause of the same. According to a study published in the World Journal of Orthopedics in 2017, hallux rigidus is a degenerative disease of the first MTP joint. Moreover, it is estimated that the disease affects 1 in every 40 people, aged 50 or more. Females are greatly affected by the disease as compared to males, .i.e., by a ratio of 2:1.  Therefore, increasing prevalence of hallux rigidus and growing female population are the major drivers for the market growth during the forecast period. Additionally, increasing demands for minimally invasive procedures and rising healthcare expenditure is estimated to fuel the market. According to the World Health Organization, the geriatric population is projected to grow from an estimated 524 million in 2010 to approximately 1.5 billion by 2050. However, high procedural cost followed by complications like deep vein thrombosis, need for repeated surgery, stiffness in the joints of the toes and low per capita healthcare expenditure in the middle and low-income countries is estimated to restrain the market growth during the projected period. According to the Fairfield Independent Hospital, the procedural cost for the same in 2016 was estimated to be around USD 3,545.

The global cheilectomy market is expected to grow at a CAGR of 7.8% during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5470 

 Segmentation:

The global cheilectomy market is segmented by the method, anesthesia, medication, and end-user.

By the method, the market is segmented into open, arthroscopic, and percutaneous method.

By the anesthesia, the market is categorized into general anesthesia, local anesthesia, and regional anesthesia. By the medication, the market is segmented into prescription pain relievers, OCT, and others. By prescription the pain relievers the market is segmented into corticosteroids, opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and others. By the OCT drugs, the market is segmented into ibuprofen, naproxen, and others. By end users, the market is segmented into hospitals & clinics, academic institutes, retail pharmacies, and others.

Regional Analysis:

The Americas dominate the global cheilectomy market owing to a well-developed healthcare sector and increasing the prevalence of hallux rigidus. Moreover, increasing healthcare expenditure and presence of the key players within the regions boosts the growth of the market in the Americas. Additionally, increasing geriatric population and growing female population fuels the regional market growth.

Europe is the second largest cheilectomy market, which is followed by Asia Pacific. Osteoarthritis is a common condition that may lead to hallux rigidus. Thus, increasing prevalence of the disease within the region drives the market growth. According to the Arthritis Research U.K in 2013, osteoarthritis was estimated to be the most common musculoskeletal condition in the geriatric population. Additionally, it was estimated that approximately, 8.75 million people within the region had sought some treatment for osteoarthritis.

Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies like India & China, and presence of huge opportunity in the market.

On the other hand, the Middle East & Africa has the least share in the global cheilectomy market due to the presence of poor economy, especially in the Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.

Key players in global cheilectomy market

The key players for the global cheilectomy market are Henry Schein, Inc. (U.S.), STEROID S.p.A. (Italy), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), Sanofi (France), Janssen Pharmaceuticals, Inc. (Belgium), PurduePharma (U.S.), ALLERGAN (Republic of Ireland), Boehringer Ingelheim International GmbH (Germany), and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/cheilectomy-market-5470 

Dental Surgical & Diagnostic Devices Market – Insights on Upcoming Trends 2027

 Market Scenario

Dental issues are one of the most common problems across the globe. Dental diagnostic and surgical devices are used to identify the nature or cause of a certain dental problem. Recently, dental diagnostic devices have been getting attention due to their extensive use in the forensic sciences. Rising number of patient with tooth decay, oral cancer, tooth erosion, tooth sensitivity, gum disease, and increasing awareness about hygiene among people drive the global market. Moreover, increasing geriatric population, increasing risk of different types of infections, poor diet, and rapid developments in the medical devices have fueled the growth of the market. However, poor reimbursement policies and high cost of the devices may hinder the growth of market.

The global dental diagnostic and surgical devices market is expecting a healthy growth at a CAGR of 11.2% during the forecast period 2017-2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/724 

Key Players in the global dental surgical & diagnostic devices market

3M (US), A-dec Inc. (US), Carestream Health (US), Danaher (US),  American Medicals (US),  Dentsply Sirona. (Germany), Ivoclar Vivadent AG (Liechtenstein), Hu-Friedy Mfg. Co., LLC (US),  PLANMECA OY (Finland), Midmark Corp. (US), KaVo Kserr (US), GC Corporation (Japan), DCI (US).

Segmentation

The global dental surgical and diagnostic devices market is segmented into product types, applications, and end users. The market is segmented on the basis of product type: CAD/CAM systems, dental chairs, dental radiology devices, CBCT scanners, scaling units, dental lasers. CAD/CAM systems is further segmented into full in-lab systems, stand-alone scanners, and chair-side systems. Dental radiology devices are further segmented into Phosphor Storage Plates (PSP), digital x-ray, accessories, dental imaging devices. Dentals lasers market is further segmented into soft tissue laser and all hard tissue laser market.  The soft tissue laser is subdivided into gas laser, diode laser and solid state lasers.

On the basis of application the market is segmented into bone abnormalities, cysts, fractures, reconstructive postmortem dental profiling, and comparative dental identification. On the basis of end users the market is segmented into dentists, hospitals, and others.

Regional Analysis

America continues to dominate the global dental surgical & diagnostic devices market owing to the presence of a large number of people with periodontitis and increasing geriatric population. In addition to this, adoption of smoking, high intake of diabetic medication including steroids, cancer therapy drugs, oral contraceptives, and others contribute to the growth of the market. Europe holds the second position in market, which is followed by Asia Pacific. Asia Pacific is the fastest growing market in the globe because of large population in developing countries are with poor oral hygiene, and the presence of huge opportunities for the development of the market. However, the Middle East & Africa accounts the least share in the global market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/dental-surgical-diagnostic-devices-market-724 

Future Growth of HIDA Scan Market is Expected to Grow Healthy CAGR till 2027

 Market Synopsis of the Global HIDA Scan Market

Also known as cholescintigraphy and hepatobiliary scintigraphy, HIDA scan is an imaging test used for the diagnosis of a number of problems such as liver, gallbladder, and bile duct. Cholecystitis, bile duct obstruction, biliary atresia, postoperative complications, and assessment of liver transplant are the major indications that can be diagnosed using HIDA scan, which is a better alternative to CT, MRI, and X-ray examination. During HIDA scan, a radioactive tracer, injected in the vein, travels through the bloodstream to the liver, and the bladder and screen the same for any abnormality.

Gall bladder diseases affect a large number of people in the world. Approximately, 10–15% of adults in the developed countries are suffering from gallstones. Gallbladder and biliary related diseases occurred in about 104 million people (1.6%) in 2013.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5231 

The global HIDA market is driven majorly by increasing number of people suffering from gall bladder diseases, development of technologically advanced devices, increasing awareness among people about diagnosis of gall bladder, and liver disease. Additionally, increasing healthcare expenditure by developed economies such as the U.S is another important factor for fuelling the growth of the market. Moreover, increasing geriatric population, and introduction of new & advanced diagnostic options to cure gallbladder problems have fuelled the market growth

The Global HIDA Scan Market is expected to grow at a CAGR of 4.2% during the forecast period.

Intended Audience

• Arthritis Drug Manufacturers
• Arthritis Drug Suppliers
• Medical Research Laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Potential Investors 

Key Players in the Global HIDA Scan Market         

Some of the key players in this market are Houston Medical Imaging (U.S.), Bracco Diagnostic Inc. (U.S.), Buffalo MRI (U.S.), Siemens (U.S.), DDD- Diagnostics A/S (Germany), Digirad Corporation (U.S.), General Electric Company (U.S.), Koninklijke Philips N.V. (Japan), Toshiba Medical Systems Corporation (Japan), and others.

Segments

The global HIDA scan market is segmented on the basis of product, indication, and end user.

On the basis of product, the market is segmented into radiopharmaceuticals, HIDA Scan, and others.

On the basis of indication, the market is segmented into cholecystitis, bile duct obstruction, biliary atresia, postoperative complications, assessment of liver transplant, and others. Postoperative complications is sub-segmented into bile leaks, and fistulas.

On the basis of end user, the market is segmented into orthopedic hospitals & clinics, diagnostic centers, and others.

Regional Analysis of the Global HIDA Scan Market                      

Considering the global scenario of the gall bladder treatment market, there are four main regions: America, Europe, Asia Pacific, and the Middle East & Africa.

America accounts for the largest market share owing to the presence of huge patient population suffering from gall bladder diseases. A well-developed healthcare sector and high healthcare spending has also accelerated the growth of the market. America consists of two regions namely, North America and South America. North America is the major market share holder owing to the presence of key players in the market offering radioactive imaging technology devices. Additionally, the key players in the market are focusing on strategies such as acquisition, partnerships, product development, and others.

Europe holds the second largest market share in global HIDA scan market. Some major factors that attribute the growth of Europe gall bladder treatment market is, increasing government support for researched development in diagnosis of chronic diseases. Germany, France and U.K are the major contributors to the Europe gall bladder treatment market owing to increasing demand for the technological advanced devices, and overall growth of healthcare sector.

Asia Pacific is the fastest growing market. Improving healthcare infrastructure, presence of huge patient population, rising awareness about gall bladder treatment has driven the growth for this market in Asia Pacific. India is expected to be the fastest growing market owing to increasing government support for healthcare industry, and increasing demand for new imaging devices in the market.

The Middle East & Africa account for the lowest share in the global HIDA scan owing to positive growth of healthcare sector form last few years. This limited growth is mainly due to lack of awareness of the disease, and limited access to the healthcare facilities. While due to developed healthcare infrastructure, government support and increasing healthcare expenditure, the Middle Eastern countries like United Arab Emirates (UAE), and Saudi Arabia are dominating this market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/hida-scan-market-5231 

Point of Care Blood Gas and Electrolyte Market to Witness Widespread Expansion During 2020 to 2027

 Point of care blood gas and electrolyte analyzers helps to measure different parameters of whole blood samples, such as blood gas (pCO2 and pO2), pH, and electrolytes. It is one of the innovative concepts that is introduced in the field of critical care settings to deliver decentralized, patient-centric health care to the patients. These devices are playing an important role in the field of healthcare and help in reducing therapeutic turnaround time, enhance patient satisfaction, accuracy, and quick test, and help to improve hospital operations. This new technology provides smaller handheld devices with advancements in diagnostic sensors.

Point of care blood gas and electrolyte devices are used majorly in the area of hospitals where patients are being ventilated. Increase in the treatments in NICUs, ICUs, Cardiovascular Operating Room (CVOR), and emergency department has boosted the point of care blood gas and electrolyte devices market growth. Additionally, rising prevalence of chronic diseases and cancer fuels the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5085 

According to the Centers for Disease Control and Prevention, in 2015, the number of adults with diagnosed chronic bronchitis and emphysema were 9.3 million and 3.5 million respectively. Additionally, according to WHO in 2016, over 1.9 billion adults aged 18 years and older were obese, which was approximately 650 million. Overall 13% of world’s adult population (11% of men and 15% of women) were obese. These diseases are the main cause of the immense growth of treatment in NICUs, ICUs, Cardiovascular Operating Room (CVOR), and emergency department. Point of care blood gas developers is now focusing on developing automated and user-friendly devices, which may lead the market of this product in the coming future. Healthcare expenditure across the world is rapidly increasing. From the last decade, healthcare expenditure in regions like the Americas and Europe has been growing rapidly. According to the Centers for Medicare & Medicaid Services, in 2015, the U.S. healthcare spending was increased by 5.8% and reached USD 3.2 trillion.

The market is expected to grow at a CAGR of 7.8% during the forecast period and is estimated to cross USD 2,543.1 million by 2027. 

Segments:                                                                                                                                           

The global POC blood gas and electrolyte devices market has been segmented on the basis of types and end users.

On the basis of the types, the market is segmented into consumables and Instruments. Furthermore, the instrument is segmented into benchtop and portable devices. The consumable devices are further segmented into reagents, cartridges, and others.

On the basis of end users, the market is segmented into hospitals & clinics, home care, research institutions, and others. 

Regional analysis:                   

Considering the global scenario of the market, the Americas dominates the global point of care blood gas and electrolyte market owing to the presence of a huge patient population with a chronic diseases like diabetes, kidney and liver disease and increasing government support for research & development. Additionally, concentration of leading players in this region accounts for the major share of the global market. According to Centers for Disease Control and Prevention (CDC), 30.3 million people of all age group of the U. S. population diagnosed with diabetes in 2015. Rapidly rising diabetic patient population increases the footfall in hospitals, and create the immense demands for POC blood gas and electrolyte devices. 

Europe is the second largest market, which is followed by Asia Pacific owing to the presence of well-developed healthcare sector, strong government support for research & development and high healthcare expenditure. Regionally, Europe is divided into Germany, France, the U.K, Italy, Spain, and Rest of Western Europe. Germany and the U.K are the major contributors to the European market growth.

Asia Pacific is also witnessing a rapid growth in this market due to rapidly increasing diabetic & obese population and rising healthcare expenditure. According to the WHO, 60% of world’s total diabetic population lives in Asia Pacific region. Additionally, the presence of rapidly developing economies like India and China likely to fuel the market growth over the forecast period.

The Middle East & Africa hold the least share of the market due to poor political conditions in Africa, and limited availability of funds and medical facilities. The Middle East holds the major share of the Middle East & Africa region due to the presence of well-developed countries like Kuwait, Qatar, Oman, and Saudi Arabia. Whereas, African region is expecting a healthy growth due to the presence of a huge opportunity for the development of the market during the review period. 

Key Findings:

• Consumables product segment accounts for the largest market share of 61.5% while the instruments segment is projected to grow at a CAGR of 6.3% during the forecast period from 2017 – 2023
• Hospitals & clinics dominates the global POC blood gas and electrolyte market with nearly 58.4% share of the global market, by end users
• Americas POC blood gas and electrolyte market is estimated to be USD 600.2 million in 2016

Key players:                                                                                                         

Some of the major players in this market are Siemens, Abbott, F. Hoffman-La Roche Ltd., Radiometer, Nova medical, Edan Instruments Inc., and Instrumentation Laboratory.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/poc-blood-gas-and-electrolyte-market-5085